Potassium Ion

Potassium Ion

SCHEMBL8612904

O=C([O-])c1c[nH]c(=S)n1C1CCc2c(F)cc(F)cc21.[K+]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.34
TDP1 Q9NUW8 1/20 0.32
NR1I2 O75469 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
CMA1 P23946 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8611550 0.88 TDP1 (0.40) HSD11B1TDP1NR1I2TRPM8CMA1
SCHEMBL8611148 0.82 RIPK1 (0.34) TDP1CMA1
Potassium Ion SCHEMBL6959314 0.78 TDP1 (0.30) TDP1
Potassium Ion SCHEMBL8613013 0.76 TDP1 (0.32) TDP1
SCHEMBL6952411 0.68 TDP1 (0.39) TDP1
SCHEMBL6959664 0.68 DBH (0.36) HSD11B1
SCHEMBL6953224 0.66 TDP1 (0.39) TDP1
SCHEMBL6957692 0.65
SCHEMBL8612852 0.64 TDP1 (0.41) TDP1
SCHEMBL6954011 0.63 HRH4 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed